Molecular Targets & Therapeutics

News

All

Transfer

Public Engagement

Awards & Grants

Diabetes

Stem Cells

Environmental Health

Computational Health

Bioengeineering

Molecular Targets & Therapeutics

Pioneer Campus

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, SAT,

Fine-Tuning Immunity: The Role of Ubiquitination in T cell Activation

A new study reveals how two key molecular players – the linear ubiquitin chain assembly complex (LUBAC) and TRAF6 – work together to fine-tune immune signaling in T cells. Published in Nature Communications, the research from the group of Prof.…

NMR spectroscopy techniques

Events, Molecular Targets and Therapeutics, STB,

Biomolecular Breathing and the 4D View of Life: Insights from the BNMRZ Symposium

How do biomolecules breathe? This question guided the recent international symposium “Ultra-Highfield NMR and 4D Structural Biology – From Mechanisms to Therapies”, hosted by the Bavarian NMR Center (BNMRZ), a joint infrastructure of Helmholtz Munich…

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, MCD,

Triggering Cell Death in Metastatic Melanoma and Lung Adenocarcinoma May Pave the Way for New Cancer Treatments

Two new studies published in Nature show that metastatic melanoma and lung adenocarcinoma rely on the protein ferroptosis suppressor protein 1 (FSP1) for survival – identifying a metabolic dependency that may inform the development of new cancer…

HMGU_Icon_Molecular_Targets

Featured Publication, Molecular Targets and Therapeutics, STB,

New Switch for Natural Cell Death Identified

In the fight against disease, programmed cell death – also known as apoptosis – is a key protective function of the body. It breaks down cells that are damaged or have undergone dangerous changes. However, cancer cells often manage to override this…

PURA Spendenübergabe

Molecular Targets and Therapeutics, STB,

PURA Syndrome Deutschland Makes Donation to Support Research at Helmholtz Munich

PURA Syndrome Deutschland e.V., a patient organization supporting families affected by the rare neurodevelopmental disorder PURA syndrome, has donated 10,000 Euros to Prof. Dierk Niessing’s research group at the Institute of Structural Biology at…

Prof. Ulrike Protzer erhält Bundesverdienstkreuz

Awards & Grants, Molecular Targets and Therapeutics, VIRO,

Ulrike Protzer Receives the Federal Cross of Merit

On October 28, 2025, Prof. Dr. med. Ulrike Protzer was awarded the Bundesverdienstkreuz (Federal Cross of Merit). This honor recognizes her outstanding contributions to the field of virology – particularly her pioneering translational research…